Dr. Schreeder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Cci Dr Nw
Huntsville, AL 35805Phone+1 256-705-4224Fax+1 256-705-4135
Education & Training
Emory University School of MedicineResidency, Internal Medicine, 1973 - 1976
Tulane University School of MedicineClass of 1973
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
AZ State Medical License 1978 - Present
AL State Medical License 1979 - 2024
TN State Medical License 1990 - 1996
GA State Medical License 1975 - 1977- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Protocol for Radiofrequency Ablation of Pulmonary Neoplasms Start of enrollment: 2003 Jun 01
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 02
Publications & Presentations
PubMed
- 28 citationsThe expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk o...David G. Hicks, Bagi R Janarthanan, Ramya Vardarajan, Swati Kulkarni, Thaer Khoury
BMC Cancer. 2010-03-22 - 59 citationsIrinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results ...Robert C.G. Martin, Charles R. Scoggins, Dana Tomalty, Marshall T. Schreeder, Tiffany Metzger
Journal of Gastrointestinal Surgery. 2012-04-24 - 100 citationsRandomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.Robert C.G. Martin, Charles R. Scoggins, Marshall T. Schreeder, William S. Rilling, Christopher J. Laing
Cancer. 2015-10-15
Press Mentions
OneOncology Partners With Huntsville's Clearview Cancer InstituteJanuary 17th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
